Latest news with #JohnKao
Yahoo
23-07-2025
- Business
- Yahoo
High Quality, Increased Member Satisfaction, Better Access to Care and Improved Outcomes Highlight Alignment Healthcare's Impact in 2024
New report outlines impact of company's commitment to always putting seniors first ORANGE, Calif., July 23, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC) today released its 2024 Impact Report outlining how it continued to deliver high-quality, personalized care to seniors while creating a positive impact on its members, providers, employees and the communities it serves. "As America's senior population rapidly grows, Alignment Healthcare is redefining what's possible in health care by combining compassion, innovation and accountability," said John Kao, founder and CEO, Alignment Healthcare. "Our Impact Report reflects our commitment to putting seniors first, empowering providers, leveraging data-driven care, and leading with a serving heart to create a better way to age in America." Noteworthy Highlights from the 2024 Impact Report include:Better Access to Care Served 11,500 members through the company's signature Care Anywhere program in 2024, a 35% increase from 8,500 members in 2023. The program helped remove barriers to access for high-risk members by offering in-home and virtual care, supported by a 24/7 virtual care center. Drove a 95% year-over-year increase in ACCESS On-Demand Concierge Card transactions to 3.1 million in 2024, almost double the use of eligible grocery purchases and over-the-counter items. Usage of the debit card grew from 97,000 members in 2023 to 151,000 in 2024. Expanded caregiver benefit access by almost 86%, with eligible members rising from 63,000 in 2023 to 117,000 in 2024. Launched in 2023, Alignment's benefit recognizes and supports those caring for the aging population. Improved Health Outcomes Achieved the company's lowest hospitalization rate to date: 149 hospitalizations per 1,000 members in 2024 – down nearly 4.5% from 156 hospitalizations per 1,000 members in 2023. This reflects impact of Alignment's proactive, preventive care approach. Reported 47% fewer skilled nursing facility admissions compared to the 2019 Medicare fee-for-service (FFS) benchmark, up from a 45% reduction in 2023. Delivery of Innovative, Data-Driven Care Enhanced care delivery through the integration of new capabilities in AVA®, Alignment's proprietary technology platform, including streamlined health risk assessments and condition tracking; simplified mental health benefit navigation and in-network appointment scheduling; and virtual care coordination enhancements such as integrated on-demand visit scheduling and appointment booking tools. Reduced 45 minutes of administrative wait time per member by leveraging AVA's provider integration. Increased Quality and Member Satisfaction Increased percentage of members enrolled in 4-star or higher-rated plans from 90% in 2023 to 100% of members in 2024. Achieved an overall Net Promoter Score (NPS) of 61, significantly higher than the industry average of 40, with the Care Anywhere program earning an NPS of 78. Maintained an average 4.9-out-of-5 Google review rating across more than 10,000 reviews. Commitment to Employees and Serving Responsibly Prioritized employee well-being and experience while offering comprehensive benefits, resulting in an 89% participation rate in the annual employee engagement survey and a 77% engagement index. Reduced greenhouse gas emissions by 36% compared to 2023, which is roughly equivalent to the annual energy use of 43.5 average U.S. homes or charging 26 million smartphones.1 The 2024 Impact Report reinforces Alignment's mission to provide compassionate, personalized care that addresses the holistic needs of America's growing senior population. To learn more, visit About Alignment HealthAlignment Health is championing a new path in senior care that empowers members to age well and live their most vibrant lives. A consumer brand name of Alignment Healthcare (NASDAQ: ALHC), Alignment Health's mission-focused team makes high-quality, low-cost care a reality for its Medicare Advantage members every day. Based in California, the company partners with nationally recognized and trusted local providers to deliver coordinated care, powered by its customized care model, 24/7 concierge care team and purpose-built technology, AVA®. As it expands its offerings and grows its national footprint, Alignment upholds its core values of leading with a serving heart and putting the senior first. For more information, visit Media ContactPriya ShahmPR, Inc. for Alignment Healthalignment@ 1 US EPA. (2025, February 24). Greenhouse Gas Equivalencies Calculator. US EPA. in to access your portfolio
Yahoo
16-05-2025
- Business
- Yahoo
ALHC Q1 Earnings Call: Membership Growth and Margin Expansion Drive Upbeat Outlook
Health insurance company Alignment Healthcare (NASDAQ:ALHC) announced better-than-expected revenue in Q1 CY2025, with sales up 47.5% year on year to $926.9 million. The company expects next quarter's revenue to be around $957.5 million, close to analysts' estimates. Its non-GAAP profit of $0.05 per share was significantly above analysts' consensus estimates. Is now the time to buy ALHC? Find out in our full research report (it's free). Revenue: $926.9 million vs analyst estimates of $888.1 million (47.5% year-on-year growth, 4.4% beat) Adjusted EPS: $0.05 vs analyst estimates of -$0.07 (significant beat) Adjusted EBITDA: $20.18 million vs analyst estimates of $4.4 million (2.2% margin, significant beat) The company lifted its revenue guidance for the full year to $3.79 billion at the midpoint from $3.75 billion, a 1.2% increase EBITDA guidance for the full year is $49 million at the midpoint, above analyst estimates of $47.1 million Operating Margin: -0.6%, up from -6.5% in the same quarter last year Free Cash Flow was $8.36 million, up from -$17.36 million in the same quarter last year Customers: 217,500, up from 189,100 in the previous quarter Market Capitalization: $2.95 billion Alignment Healthcare began 2025 with a notable increase in membership and year-over-year revenue, propelled by its ability to manage medical costs and scale its clinical care model. CEO John Kao credited the company's approach to serving seniors, particularly through care coordination for complex and dually eligible populations, as key to its success. Kao emphasized, "Our model combines the product control and data visibility of a health plan, clinical insights of a modern technology platform, medical management expertise of a care delivery organization and member experience of a consumer-first company." Looking forward, management raised full-year revenue and profit guidance, citing strong enrollment momentum and favorable industry dynamics. CFO Thomas Freeman highlighted the company's operational leverage and prudent approach to medical and pharmacy cost trends. He noted that Alignment plans to channel some early-year gains into member engagement and provider partnerships, aiming to build a durable growth platform as the Medicare Advantage landscape continues to evolve. Alignment Healthcare's management attributed the first quarter's growth to robust membership gains and strong execution in medical cost management. The following insights emerged from their remarks: Membership Expansion: The company grew membership by approximately 32%, with significant gains both in California and ex-California markets. Management pointed to the scalability of its clinical model and care coordination capabilities as core drivers. Clinical Model Scaling: The scaling of the AVA (Alignment's technology-enabled care model) enabled improved identification and engagement of high-risk seniors. This allowed for proactive care management, especially for dually eligible and chronically ill members, which management believes sets Alignment apart. Medical Cost Control: Alignment reported better-than-expected improvement in its medical benefit ratio (MBR), highlighting effective inpatient utilization management and favorable prior-year reserve releases. Management noted that these trends supported margin expansion despite rapid top-line growth. Strategic Technology Investment: Ongoing advances in the AVA platform are targeted at automating member experience and optimizing care outcomes. Management described a focus on efficacy and adoption rates of AVA modules, with plans to double down on those delivering measurable value. Leadership Transition: The company announced the transition of its long-serving CFO Thomas Freeman to a strategic advisor role, with Jim Head, a veteran healthcare finance executive, stepping in as the new CFO. Management framed this as a step to support Alignment's next phase of growth and scaling. Management outlined a constructive outlook for 2025, driven by membership growth, operational efficiencies, and continued investments in technology and partnerships. The main themes shaping guidance are: Provider Collaboration Focus: Management plans to deepen long-term partnerships with providers, especially to better serve high-need seniors. These collaborations are expected to support both growth and cost control efforts. Technology and Data Leverage: Continued investment in the AVA platform aims to advance clinical quality and member experience, with the goal of automating and personalizing care at scale. Management believes this will further distinguish Alignment in a competitive Medicare Advantage market. Regulatory and Competitive Factors: Management highlighted the impact of new Medicare Advantage payment rates and risk model changes, noting that Alignment's high plan quality ratings and efficient cost structure position it to benefit relative to some competitors. However, they acknowledged ongoing uncertainties regarding policy changes and market behavior. Ryan Daniels (William Blair): Asked about plans for expanding provider partnerships and possibly offering technology solutions externally. Management indicated that, while expansion is underway, any move into external enablement will be approached cautiously and only if it is sustainable. Michael Ha (Baird): Inquired about the drivers behind medical loss ratio outperformance and the potential pull-forward of earnings from Part D changes. Management clarified that Part D timing was a minor factor and that broader utilization trends and reserves management were more significant. Jessica Tassan (Piper Sandler): Queried about competitive changes in California and how Alignment will prepare its salesforce for increased rivalry. Management said it feels well-positioned due to partnership strengths and does not view smaller competitors as a long-term threat. Whit Mayo (Leerink Partners): Sought clarity on Alignment's risk adjustment revenue processes for new members and visibility on reimbursement. Management explained its conservative approach, booking revenue based on actual payments to avoid surprises. Joanna Gajuk (Bank of America): Asked if further Medicare Advantage rate changes could be a headwind or opportunity for market share. Management stated that its business model is designed to adapt to either environment, emphasizing focus on cost and quality. In the coming quarters, the StockStory team will be monitoring (1) the scalability of Alignment's AVA technology platform in new and existing markets, (2) the company's ability to sustain membership growth while preserving or improving margins, and (3) further developments in provider partnerships and regulatory policy changes affecting Medicare Advantage. Execution on these priorities will be central to evaluating Alignment's trajectory. Alignment Healthcare currently trades at a forward EV-to-EBITDA ratio of 51.8×. Should you load up, cash out, or stay put? Find out in our free research report. Donald Trump's victory in the 2024 U.S. Presidential Election sent major indices to all-time highs, but stocks have retraced as investors debate the health of the economy and the potential impact of tariffs. While this leaves much uncertainty around 2025, a few companies are poised for long-term gains regardless of the political or macroeconomic climate, like our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 176% over the last five years. Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
03-05-2025
- Business
- Yahoo
Why Alignment Healthcare, Inc. (ALHC) Went Down On Friday
We recently published a list of . In this article, we are going to take a look at where Alignment Healthcare, Inc. (NASDAQ:ALHC) stands against other Friday's worst performers. Wall Street's major indices ended the trading week on a strong note, clocking in robust gains as investors cheered better-than-expected non-farm payrolls last month while digesting more corporate earnings results. The tech-heavy Nasdaq led the rally among all major indices, finishing up 1.51 percent. The S&P 500 clocked in a 1.47-percent gain, while the Dow Jones grew by 1.39 percent. Despite the broader market optimism, 10 companies managed to register declines amid dismal earnings performance in the first quarter of the year. In this article, let us explore Friday's 10 worst performers and the reasons behind their decline. To come up with the list, we considered only the stocks with a $2-billion market capitalization and $5-million trading volume. A doctor holding a clipboard talking to an elderly patient in a Medicare Advantage healthcare facility. Alignment Healthcare, Inc. (NASDAQ:ALHC) Alignment Healthcare dropped its share prices by 7.39 percent on Friday to finish at $15.53 apiece as investors immediately booked profits after a surge during the intra-day session, supported by its impressive earnings performance in the first quarter of the year. In a statement, Alignment Healthcare, Inc. (NASDAQ:ALHC) said that it narrowed its net loss by 80 percent to $9.35 million from $46.5 million in the same period last year. Revenues increased by 47 percent to $927 million from $629 million year-on-year. Looking ahead, the company said that it is gunning for revenues between $950 million and $965 million in the second quarter of the year, to between $3.77 billion and $3.8 billion in the full-year period. Adjusted EBITDA is also expected to settle at $10 to $18 million in the second quarter, and to $38 to $60 million in full-year 2025. 'By staying focused on quality, clinical outcomes, and member experience, we exceeded expectations across all key measures. With a strong start to the year and momentum building, we're confident in our ability to scale with purpose and deliver on our mission of Medicare Advantage done right,' said Alignment Healthcare, Inc. (NASDAQ:ALHC) CEO John Kao. Overall, ALHC ranks 9th on our list of Friday's worst performers. While we acknowledge the potential of ALHC as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than ALHC but that trades at less than 5 times its earnings, check out our report about this cheapest AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
Yahoo
01-05-2025
- Business
- Yahoo
Alignment Healthcare (NASDAQ:ALHC) Reports Upbeat Q1, Full-Year Outlook Slightly Exceeds Expectations
Health insurance company Alignment Healthcare (NASDAQ:ALHC) beat Wall Street's revenue expectations in Q1 CY2025, with sales up 47.5% year on year to $926.9 million. Guidance for next quarter's revenue was better than expected at $957.5 million at the midpoint, 1.3% above analysts' estimates. Its GAAP loss of $0.05 per share was 59.7% above analysts' consensus estimates. Is now the time to buy Alignment Healthcare? Find out in our full research report. Revenue: $926.9 million vs analyst estimates of $888.1 million (47.5% year-on-year growth, 4.4% beat) EPS (GAAP): -$0.05 vs analyst estimates of -$0.12 (59.7% beat) Adjusted EBITDA: $20.18 million vs analyst estimates of $4.40 million (2.2% margin, significant beat) The company lifted its revenue guidance for the full year to $3.79 billion at the midpoint from $3.75 billion, a 1.2% increase EBITDA guidance for the full year is $49 million at the midpoint, above analyst estimates of $47.1 million Operating Margin: -0.6%, up from -6.5% in the same quarter last year Free Cash Flow was $8.36 million, up from -$17.36 million in the same quarter last year Customers: 217,500, up from 189,100 in the previous quarter Market Capitalization: $3.50 billion 'Alignment Healthcare's first-quarter performance reflects the strength of our model and the discipline of our execution, showing what's possible when technology, clinical management and member-first service operate as one,' said John Kao, founder and CEO. Founded in 2013 with a mission to transform healthcare for seniors, Alignment Healthcare (NASDAQ:ALHC) provides Medicare Advantage health plans for seniors with features like concierge services, transportation benefits, and technology-driven care coordination. A company's long-term sales performance can indicate its overall quality. Any business can put up a good quarter or two, but the best consistently grow over the long haul. Thankfully, Alignment Healthcare's 30.3% annualized revenue growth over the last five years was incredible. Its growth beat the average healthcare company and shows its offerings resonate with customers, a helpful starting point for our analysis. Long-term growth is the most important, but within healthcare, a half-decade historical view may miss new innovations or demand cycles. Alignment Healthcare's annualized revenue growth of 40.2% over the last two years is above its five-year trend, suggesting its demand was strong and recently accelerated. We can dig further into the company's revenue dynamics by analyzing its number of customers, which reached 217,500 in the latest quarter. Over the last two years, Alignment Healthcare's customer base averaged 38.8% year-on-year growth. Because this number is in line with its revenue growth, we can see the average customer spent roughly the same amount each year on the company's products and services. This quarter, Alignment Healthcare reported magnificent year-on-year revenue growth of 47.5%, and its $926.9 million of revenue beat Wall Street's estimates by 4.4%. Company management is currently guiding for a 40.5% year-on-year increase in sales next quarter. Looking further ahead, sell-side analysts expect revenue to grow 32.6% over the next 12 months, a deceleration versus the last two years. Despite the slowdown, this projection is commendable and implies the market sees success for its products and services. Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we've identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link. Operating margin is a key measure of profitability. Think of it as net income - the bottom line - excluding the impact of taxes and interest on debt, which are less connected to business fundamentals. Although Alignment Healthcare broke even this quarter from an operational perspective, it's generally struggled over a longer time period. Its expensive cost structure has contributed to an average operating margin of negative 6.2% over the last five years. Unprofitable healthcare companies require extra attention because they could get caught swimming naked when the tide goes out. On the plus side, Alignment Healthcare's operating margin rose by 3 percentage points over the last five years, as its sales growth gave it operating leverage. This performance was mostly driven by its recent improvements as the company's margin has increased by 6 percentage points on a two-year basis. These data points are very encouraging and shows momentum is on its side. This quarter, Alignment Healthcare generated a negative 0.6% operating margin. Revenue trends explain a company's historical growth, but the long-term change in earnings per share (EPS) points to the profitability of that growth – for example, a company could inflate its sales through excessive spending on advertising and promotions. Alignment Healthcare's earnings losses deepened over the last five years as its EPS dropped 13.2% annually. We'll keep a close eye on the company as diminishing earnings could imply changing secular trends and preferences. In Q1, Alignment Healthcare reported EPS at negative $0.05, up from negative $0.25 in the same quarter last year. This print easily cleared analysts' estimates, and shareholders should be content with the results. Over the next 12 months, Wall Street is optimistic. Analysts forecast Alignment Healthcare's full-year EPS of negative $0.48 will reach break even. We were impressed by how significantly Alignment Healthcare blew past analysts' revenue, EPS, and EBITDA expectations this quarter. We were also glad it raised its full-year revenue and EBITDA guidance. Overall, we think this was a solid quarter with some key metrics above expectations. The stock remained flat at $16.77 immediately after reporting. Alignment Healthcare put up rock-solid earnings, but one quarter doesn't necessarily make the stock a buy. Let's see if this is a good investment. When making that decision, it's important to consider its valuation, business qualities, as well as what has happened in the latest quarter. We cover that in our actionable full research report which you can read here, it's free. Sign in to access your portfolio
Korea Herald
27-04-2025
- Business
- Korea Herald
Phase 3 of the 2025 Global Sources Hong Kong Shows Officially Opens
Focusing on New Opportunities in Sports, Outdoor, and Baby Products Markets HONG KONG, April 27, 2025 /PRNewswire/ -- Phase 3 of the 2025 Global Sources Hong Kong Shows officially opened today and will run until April 30 at AsiaWorld-Expo in Hong Kong. The four-day event covering two major trade shows: "Sports & Outdoor Show" and "Baby & Children's Products Show." The exhibition brings together more than 700 exhibitors from across Asia, focusing on three core areas: "Product Upgrades," "Community Scenarios," and "Customization Services," showcasing diverse products including camping supplies and equipment, fitness equipment, water sports gear, outdoor sports products, sportswear, and accessories, creating an efficient and precise international sourcing platform for global professional buyers. The concurrent Baby & Children's Products Show focuses on displaying various maternal and infant products and related services, including baby toys, strollers, safety seats, and baby furniture. The exhibition is expected to attract nearly 15,000 visitors, promoting industry exchange and business cooperation. Sports & Outdoor Show: World Cup-Themed Area Leads the Trend With the 2026 World Cup approaching, global sourcing demand for sports products is expected to rise significantly. The show has specially set up a "World Cup-themed Area," showcasing diverse categories including sports equipment, apparel, souvenirs, and customized promotional items. The area brings together international brand manufacturing partners and vertical domain specialists to precisely meet market demands. Exhibitors will showcase products made from sustainable materials, responding to global market concerns about green manufacturing. For example, Maxstar, which has collaborated with Pepsi and Coca-Cola, will display an eco-friendly football series made from renewable materials, injecting sustainable development value into traditional sports products; Healy Sportswear and Normzl are offering flexible B2B customization services where everything from jersey colors to team logo designs and cultural totem elements can be personalized to meet diverse market needs; while in the area of cultural derivatives, some exhibitors are breaking through homogenization challenges by combining World Cup elements with team IP to explore the cultural value-added potential of event economics. John Kao, Vice President of Hong Kong Shows & Overseas Shows at Global Sources, points out: "The World Cup is both a golden window for driving order growth and an important opportunity for companies to upgrade products and innovate services. Companies need to balance short-term order pressure with long-term brand value." Outdoor Products Moving Toward Multi-Scenario Application Era Beyond the World Cup-themed area, outdoor sports products are also showing innovative trends. A series of products such as camping equipment, mountain climbing gear, and water activity supplies are gradually transforming from single-tool attributes to carriers of lifestyle, embodying the industry development direction of "function as application scenario," injecting new momentum into the outdoor equipment market. Taking the well-known outdoor brand TMZ as an example, they are exhibiting their latest foldable camping cart, made of durable materials with scenario-based design elements that achieve seamless transition between function and usage scenarios. Its detachable oil-resistant tabletop can flexibly adapt to different outdoor situations such as transportation, dining, and barbecue, fully meeting diversified camping needs. This innovative "function as application scenario" design not only caters to market demand for multi-scenario applications but also opens up new growth space for the outdoor products industry. To enhance the on-site experience for visitors, the exhibition features multiple sports-themed activities, including a sports carnival, PICKLEBALL experience zone, and football interactive area. The exhibition also joins with the Sports Performance and Functional Fitness Federation of Hong Kong, China to organize Indoor Triathlon Invitation Competition, inviting athletes to compete on-site, vividly demonstrating the unique charm of skiing, cycling, and rowing triathlon. Meanwhile, Global Sources Hong Kong Shows is partnering for the first time with Po Leung Kuk Youth Affairs Department to organize the "Emerging Sports Promotion Day," featuring demonstrations by award-winning coaches and introducing the emerging sport "Extreme Speed Disc," which was independently developed by Po Leung Kuk and recognized by the Flying Disc Federation of Hong Kong, China and China Hong Kong Newly Emerged Sports Association. In addition, Wing Chun Master Lam Shu-shing will make a personal appearance to demonstrate Ip Man-Leung Sheung Wing Chun techniques, adding a highlight of traditional martial arts culture to the exhibition. John Kao adds: "These immersive themed activities are gradually reshaping traditional business matching methods. Through various sports experiences, buyers and suppliers can more intuitively feel product value in real application, thereby establishing deeper consensus on product functions and market needs. This is the core purpose of Global Sources setting up themed activity areas." Baby & Children's Products Show: Smart and Emotional Design Leads Industry New Directions The Baby & Children's Products Show focuses on diverse products including baby supplies, toys, clothing, strollers, safety seats, and baby furniture, aiming to build an efficient connection platform for upstream and downstream enterprises in the industry chain, promoting technological upgrades and innovative cooperation. The maternal and infant industry is currently transitioning from "meeting basic needs" to a development stage that emphasizes both "technology-enabled safety" and "emotional value co-creation." The exhibition perfectly presents this transformation, serving as a weather vane for market trends in the next six months to a year. In terms of infant care products, as scientific parenting concepts become popular, intelligent applications are increasingly mature. Exhibitor Vizolink's AI baby monitoring system integrates millimeter-wave radar with visual AI, supporting functions such as sleep apnea alerts and continuous temperature monitoring, providing real-time warnings of potential risks, greatly enhancing the safety and technological protection of family childcare, becoming an important representative of baby products moving from function-oriented to intelligent upgrades. At the same time, emotional design is rapidly emerging in the field of baby products. Brands are incorporating elements of childlike fun, aesthetics, and storytelling by combining community scenarios, not only enhancing product added value but also strengthening emotional connections between users and products, exploring new growth paths. For example, the brand Zoyzoii under Shenzhen Miker Technology Co., Ltd. focuses on children's travel product design, cleverly integrating natural elements with childlike styles, transforming practical items such as backpacks and water bottles into children's growth companions. The exhibition displays series products such as bear-shaped backpacks, mushroom-shaped backpacks, and natural-style water bottles, which are exquisite in appearance and combine practicality with emotional value, fully demonstrating the development trend of the baby products market's increasing emphasis on emotional connection and product design. 2025 marks an important milestone for Global Sources Online (GSOL) as it celebrates its 30th anniversary. As the world's first international O2O sourcing platform, GSOL continues to upgrade trade models through digital innovation and deepens online-offline integration through the "Global Sources Hong Kong Shows," building a seamlessly connected global trade ecosystem. This exhibition integrates professional digital platforms, cloud exhibition systems, and intelligent matching technology to provide full-scenario efficient connection services for buyers and sellers, continuously promoting digital transformation and further optimizing procurement experiences. In addition, the simultaneously launched Show Genie APP realizes instant entry with QR code scanning, personalized exhibition route planning, and online note-taking functions, not only significantly improving visitor efficiency but also bringing more on-site traffic and online business opportunities to exhibitors, helping trade partners seize opportunities in the digital wave. About Global Sources Global Sources is an internationally recognized multichannel Online-to-Offline (O2O) sourcing platform that has been driving global trade for over 50 years. The company connects authentic buyers and verified suppliers worldwide with tailored solutions and trusted market intelligence through its online platform mobile apps, industry-specific trade shows, and tailored business matching. Global Sources' unique services have successfully provided efficient and convenient commercial services to over 14 million registered international buyers and users.
